Login / Signup

The IDEAL (Insulin therapy DE-intensificAtion with iglarLixi) Randomised Controlled Trial-Study Design and Protocol.

Peter NovodvorskyLenka ThiemeIvana LaňkováMiloš MrázZoltán J TaybaniBalázs BótyikPéter StellaMiroslav VytasilFelipe LauandMireille BonnemaireMartin Haluzík
Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2024)
ClinicalTrials.gov, identifier NCT04945070.
Keyphrases
  • type diabetes
  • study protocol
  • randomized controlled trial
  • glycemic control
  • stem cells
  • clinical trial
  • bone marrow
  • cell therapy
  • insulin resistance
  • weight loss